PCM
SCMP

Prelude Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Prelude Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,000
Closed -$16K – 1975
2015
Q2 		$16K Buy
+1,000
New +$17.3K ﹤0.01% 1496

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Prelude Capital Management's SCMP Position: Q1 2018 in Review

Prelude Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 674,446 shares — an estimated $12.1M sold.

Prelude Capital Management first reported a position in SCMP in Q4 2013 and held it in 17 quarters. The position peaked at $12.1M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Prelude Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Prelude Capital Management sold 674,446 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $12.1M.
  • Prelude Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2013 and held it in 17 quarters.
  • Prelude Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $12.1M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Prelude Capital Management's 13F filing for Q1 2018, filed 15 May 2018.